not-found

LZVO Newsletter

#europe news
Latest EMVO newsletter on the operation of the medicines verification system – June 2023

The European Medicines Verification Organisation (EMVO) has launched a newsletter, which informs about the statement from EMVO’s new President, the roles and responsibilities of the National Medicines Verification Organisations (NMVO) Observers, the experience from the Hungarian Medicines Verification Organisation in ending the stabilisation period, the Belgium's experience with the Nordic recommendations on the recalls of batches and withdrawal of products, as well as on the status of alerts in the European Medicines Verification System (EMVS).

#news
SWS have repeatedly rated the LZVO’s customer service highly

To improve the quality of work and cooperation with its customers, in April of this year, the Latvian Medicines Verification Organisation (LZVO) conducted a survey with Software Suppliers (SWS) about the LZVO's customer service. An invitation to participate in the survey was sent to all SWS’ who cooperate with the LZVO and offer technical solutions for Latvian end users – pharmacies, hospitals, healthcare institutions and pharmaceutical wholesalers.

The Chairwoman of the Board of LZVO has been appointed as one of the NMVO Observers within EMVO’s Board

On May 12, at the European Medicines Verification Organisation’s (EMVO) General Assembly meeting, the NMVO Observers within EMVO’s Board for 2023 from the National Medicines Verification Organizations (NMVOs) were approved. As one of the observers representing the group of small-scale countries, will be the Latvian Medicines Verification Organisation (LZVO) and its Chairwoman of the Board Inese Erdmane.